Pajjiż: Irlanda
Lingwa: Ingliż
Sors: HPRA (Health Products Regulatory Authority)
CEFRADINE ARGININE
Bristol-Myers Squibb Pharmaceuticals Ltd
CEFRADINE ARGININE
1.0 Grams
Pdr for Soln Inj/Inf
Product subject to prescription which may not be renewed (A)
Withdrawn
2010-09-08
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Velosef for Injection 1 g 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 1g of cefradine. For excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for solution for injection or infusion A white to off-white free-flowing powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The treatment of infections of the urinary, respiratory tracts and of the skin and soft tissues, bones and joints; also septicaemia and endocarditis. These include: Upper respiratory infections pharyngitis, sinusitis, otitis media, tonsillitis, laryngo-tracheo bronchitis. Lower respiratory infections acute and chronic bronchitis, lobar and bronchopneumonia. Urinary tract infections cystitis, urethritis, pyelonephritis. Skin and soft tissue infections abscess, cellulitis, furunculosis, impetigo. Velosef has been shown to be effective in reducing the incidence of postoperative infections in patients undergoing surgical procedures associated with a high risk of infection. It is also of value where post operative infection would be disastrous and where patients have a reduced host resistance to bacterial infection. Protection is best ensured by achieving adequate local tissue concentrations at the time contamination is likely to occur. Thus, Velosef should be administered immediately prior to surgery and continued during the postoperative period. Bacteriological studies to determine the causative organisms and their sensitivity to Velosef should be performed. Therapy may be instituted prior to receiving the results of the sensitivity test. Sterile Velosef for injection is indicated primarily for those patients unable to tolerate oral medication. It is also indicated for intravenous use either by direct injection or by intraveno Aqra d-dokument sħiħ